why choose us

First received: December 21, 2022

Clinical Trial: A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Study Status: Completed

Recruit Status: Completed

Condition: Renal Impairment

Study Type: Interventional


Official Title: A Phase 1, Open-Label, Single Dose Parallel-Group Study of Brensocatib Following a Single Oral Administration in Subjects With or Without Renal Impairment

Brief Summary: The primary purpose of the study is to determine the pharmacokinetics (PK) following a single oral dose administration of brensocatib, safety, and tolerability of brensocatib when administered to participants with impaired renal function and in healthy participants.

Read more